Alnylam Pharmaceuticals Inc (ALNY) Insider Trading
- $71,277,732.32
- $404,324,659.91
- Feb. 18, 2025
- Akshay Vaishnaw
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 12, 2021 | COO | 3,125 | $161.00 | Sell | $503,125.00 | |
| Jan. 12, 2021 | EVP | 14,941 | $160.20 | Sell | $2,393,548.20 | |
| Dec. 18, 2020 | Director | 15,000 | $140.00 | Sell | $2,100,000.00 | |
| Nov. 25, 2020 | Director | 30,000 | $124.89 | Sell | $3,746,700.00 | |
| Sept. 29, 2020 | Insider | 971 | $140.00 | Sell | $135,940.00 | |
| Sept. 9, 2020 | President | 44,530 | $123.23 | Sell | $5,487,431.90 | |
| Aug. 20, 2020 | CEO | 34,765 | $136.13 | Sell | $4,732,559.45 | |
| July 13, 2020 | EVP | 47,250 | $160.67 | Sell | $7,591,657.50 | |
| July 9, 2020 | COO | 11,236 | $161.00 | Sell | $1,808,996.00 | |
| July 7, 2020 | President | 22,265 | $159.99 | Sell | $3,562,177.35 | |
| May 20, 2020 | CEO | 34,765 | $143.22 | Sell | $4,979,043.30 | |
| May 6, 2020 | President | 22,265 | $149.99 | Sell | $3,339,527.35 | |
| May 5, 2020 | COO | 7,811 | $140.00 | Sell | $1,093,540.00 | |
| April 20, 2020 | Insider | 21,971 | $140.00 | Sell | $3,075,940.00 | |
| April 20, 2020 | EVP | 10,000 | $139.00 | Sell | $1,390,000.00 | |
| Feb. 20, 2020 | CEO | 34,765 | $131.85 | Sell | $4,583,765.25 | |
| Feb. 10, 2020 | COO | 9,892 | $130.00 | Sell | $1,285,960.00 | |
| Feb. 10, 2020 | Director | 30,000 | $130.00 | Sell | $3,900,000.00 | |
| Feb. 7, 2020 | Insider | 23,708 | $125.00 | Sell | $2,963,500.00 | |
| Feb. 7, 2020 | COO | 6,250 | $123.90 | Sell | $774,375.00 | |
| Jan. 29, 2020 | EVP | 6,337 | $119.00 | Sell | $754,103.00 | |
| Jan. 27, 2020 | EVP | 41,037 | $117.70 | Sell | $4,830,054.90 | |
| Nov. 20, 2019 | COO | 8,404 | $105.00 | Sell | $882,420.00 | |
| Nov. 20, 2019 | Director | 75,000 | $100.00 | Sell | $7,500,000.00 | |
| Nov. 18, 2019 | Director | 15,000 | $91.71 | Sell | $1,375,650.00 | |
| Oct. 22, 2019 | President | 58,913 | $89.99 | Sell | $5,301,580.87 | |
| Oct. 14, 2019 | CEO | 49,456 | $79.45 | Sell | $3,929,279.20 | |
| May 15, 2019 | CEO | 49,457 | $70.00 | Sell | $3,461,990.00 | |
| April 15, 2019 | Director | 15,000 | $88.23 | Sell | $1,323,450.00 | |
| Aug. 30, 2018 | COO | 2,500 | $120.00 | Sell | $300,000.00 | |
| July 25, 2018 | CEO | 50,000 | $105.39 | Sell | $5,269,500.00 | |
| June 20, 2018 | SVP | 1,563 | $105.04 | Sell | $164,177.52 | |
| March 26, 2018 | COO | 7,221 | $136.54 | Sell | $985,955.34 | |
| March 20, 2018 | SVP | 1,562 | $149.83 | Sell | $234,034.46 | |
| March 14, 2018 | Insider | 88,554 | $143.10 | Sell | $12,672,077.40 | |
| March 14, 2018 | President | 38,460 | $143.10 | Sell | $5,503,626.00 | |
| March 13, 2018 | SVP | 20,000 | $145.00 | Sell | $2,900,000.00 | |
| March 13, 2018 | Director | 27,823 | $150.00 | Sell | $4,173,450.00 | |
| March 9, 2018 | Director | 15,000 | $129.00 | Sell | $1,935,000.00 | |
| Jan. 4, 2018 | VP | 36,745 | $131.59 | Sell | $4,835,274.55 | |
| Dec. 20, 2017 | SVP | 6,249 | $121.20 | Sell | $757,378.80 | |
| Dec. 1, 2017 | SVP | 30,000 | $135.89 | Sell | $4,076,700.00 | |
| Nov. 22, 2017 | CEO | 73,415 | $130.90 | Sell | $9,610,023.50 | |
| Nov. 15, 2017 | CEO | 74,000 | $126.86 | Sell | $9,387,640.00 | |
| Nov. 2, 2017 | Director | 20,000 | $130.00 | Sell | $2,600,000.00 | |
| Oct. 30, 2017 | EVP | 33,666 | $121.46 | Sell | $4,089,072.36 | |
| Oct. 2, 2017 | President | 85,316 | $125.00 | Sell | $10,664,500.00 | |
| Sept. 20, 2017 | President | 76,815 | $100.00 | Sell | $7,681,500.00 | |
| May 31, 2017 | Major Shareholder | 297,501 | $71.87 | Buy | $21,381,396.87 | |
| May 30, 2017 | SVP | 11,500 | $65.35 | Buy | $751,525.00 |
Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.
The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Yvonne Greenstreet, Laurie Keating, Pushkal Garg, Barry E Greene, Paul Schimmel, Philip A Sharp, Michael Mason, Laurence Reid, Tolga Tanguler, Jeffrey V Poulton, Sanofi, Steven M Paul, Dennis A Ausiello, Kevin P Starr, Michael W Bonney, Kevin Joseph Fitzgerald, Indrani Lall Franchini, David E I Pyott, Phillip A Sharp, Amy W Schulman, John Clarke, Kevin P. Starr, Marsha Fanucci, Philip A. Sharp, Phillip A. Sharp, and David-Alexandre C Gros
The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.
John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.
Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.
The most recent insider trade for Alnylam Pharmaceuticals Inc was on Feb. 18, 2025.
The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.
The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Pushkal Garg with a total value of $14,988,720.00 on Jan. 27, 2025.